A new multinational study found that insulin detemir, a basal insulin analog in late-stage development, achieved similar improvement in A1C levels, provided significantly lower day-to-day ...

Insulin degludec was noninferior to insulin detemir, with the insulin degludec group achieving a final HbA1c before delivery of 6.2% vs. 6.3% for women receiving insulin detemir ...

Summary: Insulin detemir is a long-acting, neutral, and soluble insulin analogue with a lower within-subject variability of fasting plasma glucose levels than isophane insulin human ...

First, insulin detemir does not precipitate following injection, and second, it binds to albumin in the circulation and the subcutaneous depot, which may buffer against changes in absorption. 14 ...

Insulin-naive patients with type 2 diabetes poorly controlled with oral antidiabetic drugs were able to achieve a hemoglobin A1c level of less than 7% after learning how to titrate their once ...

Insulin Detemir is a long-acting type of insulin. There are two other long-acting insulins sold under a number of brand names in the U.S.: Insulin Glargine and Insulin Degludec.

Insulin Detemir is a long-acting type of insulin. There are two other long-acting insulins sold under a number of brand names in the U.S.: Insulin Glargine and Insulin Degludec.

Insulin Detemir is a long-acting type of insulin. There are two other long-acting insulins sold under a number of brand names in the U.S.: Insulin Glargine and Insulin Degludec.

Novo Nordisk is discontinuing Levemir and has a shortage of some Insulin Aspart and Novolog products. Other insulin injections are not in shortage. Skip Navigation. Share on Facebook; ...

Insulin Detemir is a long-acting type of insulin. There are two other long-acting insulins sold under a number of brand names in the U.S.: Insulin Glargine and Insulin Degludec.

Insulin Detemir is a long-acting type of insulin. There are two other long-acting insulins sold under a number of brand names in the U.S.: Insulin Glargine and Insulin Degludec.